SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Bergström Christel A. S.)
 

Search: WFRF:(Bergström Christel A. S.) > Early pharmaceutica...

Early pharmaceutical profiling to predict oral drug absorption : Current status and unmet needs

Bergström, Christel A. S. (author)
Uppsala universitet,Institutionen för farmaci
Holm, Rene (author)
Jorgensen, Soren Astrup (author)
show more...
Andersson, Sara B. E. (author)
Uppsala universitet,Institutionen för farmaci
Artursson, Per (author)
Uppsala universitet,Institutionen för farmaci
Beato, Stefania (author)
Borde, Anders (author)
Box, Karl (author)
Brewster, Marcus (author)
Dressman, Jennifer (author)
Feng, Kung-I. (author)
Halbert, Gavin (author)
Kostewicz, Edmund (author)
McAllister, Mark (author)
Muenster, Uwe (author)
Thinnes, Julian (author)
Taylor, Robert (author)
Mullertz, Anette (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2014
2014
English.
In: European Journal of Pharmaceutical Sciences. - : Elsevier BV. - 0928-0987 .- 1879-0720. ; 57, s. 173-199
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Preformulation measurements are used to estimate the fraction absorbed in vivo for orally administered compounds and thereby allow an early evaluation of the need for enabling formulations. As part of the Oral Biopharmaceutical Tools (OrBiTo) project, this review provides a summary of the pharmaceutical profiling methods available, with focus on in silica and in vitro models typically used to forecast active pharmaceutical ingredient's (APIs) in vivo performance after oral administration. An overview of the composition of human, animal and simulated gastrointestinal (GI) fluids is provided and state-of-the art methodologies to study API properties impacting on oral absorption are reviewed. Assays performed during early development, i.e. physicochemical characterization, dissolution profiles under physiological conditions, permeability assays and the impact of excipients on these properties are discussed in detail and future demands on pharmaceutical profiling are identified. It is expected that innovative computational and experimental methods that better describe molecular processes involved in vivo during dissolution and absorption of APIs will be developed in the OrBiTo. These methods will provide early insights into successful pathways (medicinal chemistry or formulation strategy) and are anticipated to increase the number of new APIs with good oral absorption being discovered. (C) 2013 Elsevier B.V. All rights reserved.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Keyword

Preformulation
Physicochemical properties
Pharmaceutical profiling
Biorelevant media
Intestinal fluid
Absorption

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view